In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (281)
Report
Study: Social determinants of health influence breast cancer outcomes
April 16, 2025
To better understand how socioeconomic disparities impact breast cancer screening and care, the Evernorth Research Institute analyzed claims data of more than 168,000 women covered by commercial health insurance, Medicaid, or Medicare.
Report
Colorectal cancer screenings at a younger age help lower risk and cost of care
April 08, 2025
Screenings can help mitigate the health and cost impact of rising cases among adults under the age of 50.
Article
Get the facts: Arkansas Bill HB 1150 puts patients and families at risk
April 08, 2025
Here are the facts on what patients could lose if HB 1150 becomes law and eliminates PBM-affiliated pharmacies including retail, specialty and home delivery.
Article
Special delivery: How a Freedom Fertility pharmacist went above and beyond
March 28, 2025
Watch the story of one Freedom Fertility by Evernorth employee’s mission to ensure a patient received her time-sensitive medication.
Report
Immune checkpoint inhibitor medications: A game-changer in cancer treatments
March 27, 2025
A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.
Article
Specialty pipeline perspectives: The upcoming wave of biosimilars
March 26, 2025
Evernorth anticipates a dramatic shift in inflammatory and oncology treatments over the next five years, with dozens of biosimilars in the pipeline.
